BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22159921)

  • 21. Forkhead box protein O3 transcription factor negatively regulates autophagy in human cancer cells by inhibiting forkhead box protein O1 expression and cytosolic accumulation.
    Zhu WL; Tong H; Teh JT; Wang M
    PLoS One; 2014; 9(12):e115087. PubMed ID: 25546383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization.
    Potente M; Urbich C; Sasaki K; Hofmann WK; Heeschen C; Aicher A; Kollipara R; DePinho RA; Zeiher AM; Dimmeler S
    J Clin Invest; 2005 Sep; 115(9):2382-92. PubMed ID: 16100571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by reducing levels of reactive oxygen species.
    Deng X; Ewton DZ; Friedman E
    Cancer Res; 2009 Apr; 69(8):3317-24. PubMed ID: 19351855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase.
    Deng X; Mercer SE; Shah S; Ewton DZ; Friedman E
    J Biol Chem; 2004 May; 279(21):22498-504. PubMed ID: 15010468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of conditional lentivirus-mediated shRNA vector targeting the human Mirk gene and identification of RNAi efficiency in rhabdomyosarcoma RD cells.
    Zhao B; Yang C; Yang S; Gao Y; Wang J
    Int J Oncol; 2013 Oct; 43(4):1253-9. PubMed ID: 23913162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells.
    Chock KL; Allison JM; Shimizu Y; ElShamy WM
    Cancer Res; 2010 Nov; 70(21):8782-91. PubMed ID: 20940403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells.
    Yuan Z; Wang F; Zhao Z; Zhao X; Qiu J; Nie C; Wei Y
    PLoS One; 2011; 6(5):e20586. PubMed ID: 21655183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mirk/dyrk1B Kinase in Ovarian Cancer.
    Friedman E
    Int J Mol Sci; 2013 Mar; 14(3):5560-75. PubMed ID: 23528858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.
    Boreddy SR; Pramanik KC; Srivastava SK
    Clin Cancer Res; 2011 Apr; 17(7):1784-95. PubMed ID: 21350002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mirk/Dyrk1B in cancer.
    Friedman E
    J Cell Biochem; 2007 Oct; 102(2):274-9. PubMed ID: 17583556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
    Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
    Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 protein interacts with Class O Forkhead transcription factors in the cytoplasm and regulates nuclear/cytoplasmic localization of FoxO1 and FoxO3a proteins in CD4(+) T cells.
    Oh HM; Yu CR; Dambuza I; Marrero B; Egwuagu CE
    J Biol Chem; 2012 Aug; 287(36):30436-43. PubMed ID: 22761423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
    Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
    J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori-associated regulation of forkhead transcription factors FoxO1/3a in human gastric cells.
    Tabassam FH; Graham DY; Yamaoka Y
    Helicobacter; 2012 Jun; 17(3):193-202. PubMed ID: 22515357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells.
    Liu H; Yin J; Wang C; Gu Y; Deng M; He Z
    Anticancer Drugs; 2014 Sep; 25(8):898-907. PubMed ID: 24814195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mirk/Dyrk1b mediates cell survival in rhabdomyosarcomas.
    Mercer SE; Ewton DZ; Shah S; Naqvi A; Friedman E
    Cancer Res; 2006 May; 66(10):5143-50. PubMed ID: 16707437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical Role of AMPK/FoxO3A Axis in Globular Adiponectin-Induced Cell Cycle Arrest and Apoptosis in Cancer Cells.
    Shrestha A; Nepal S; Kim MJ; Chang JH; Kim SH; Jeong GS; Jeong CH; Park GH; Jung S; Lim J; Cho E; Lee S; Park PH
    J Cell Physiol; 2016 Feb; 231(2):357-69. PubMed ID: 26089158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The survival kinase Mirk/dyrk1B is activated through Rac1-MKK3 signaling.
    Jin K; Lim S; Mercer SE; Friedman E
    J Biol Chem; 2005 Dec; 280(51):42097-105. PubMed ID: 16257974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell receptor signaling down-regulates forkhead box transcription factor class O 1 mRNA expression via phosphatidylinositol 3-kinase and Bruton's tyrosine kinase.
    Hinman RM; Bushanam JN; Nichols WA; Satterthwaite AB
    J Immunol; 2007 Jan; 178(2):740-7. PubMed ID: 17202334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JNK-dependent downregulation of FoxO1 is required to promote the survival of fibroblast-like synoviocytes in rheumatoid arthritis.
    Grabiec AM; Angiolilli C; Hartkamp LM; van Baarsen LG; Tak PP; Reedquist KA
    Ann Rheum Dis; 2015 Sep; 74(9):1763-71. PubMed ID: 24812285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.